Adam Bataineh

Numenor operates as one of the UK’s most advanced online longevity clinics. It provides comprehensive health assessments and personalized treatment plans targeting key aging-related diseases using advanced diagnostics and evidence-based interventions. The focus includes metabolic health, cardiovascular risk, neurodegeneration prevention, cancer risk reduction, and overall lifespan extension. No clinical trial results are reported; service efficacy appears based on published research in preventative medicine. Adam Bataineh has previously co-founded Span Health—a data-driven health coaching startup focused on similar goals—which was acquired by Eight Sleep. The company positions itself at the intersection of digital healthcare delivery and longevity science. There are no disclosed investigational drugs or device programs. Dr. Bataineh also participates in public discussions about emerging therapies such as rapamycin but does not appear to run interventional trials himself.